Skip to main content

Day: September 25, 2025

Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements

Company Successfully Meets Both Minimum Bid Price and Shareholders’ Equity Requirements, Securing Continued Listing on the Nasdaq Capital Market GRAND CAYMAN, Cayman Islands, Sept. 25, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company“), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that it has received written notification from The Nasdaq Stock Market LLC (“Nasdaq“) confirming that the Company has regained compliance with both Nasdaq Listing Rules 5550(a)(2) and 5550(b)(1), concerning the minimum bid price and shareholders’ equity requirements. The letter, dated September 23, 2025, confirmed that the Company has successfully met the minimum bid price requirement...

Continue reading

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is the third-largest pharmaceutical market globally, with oncology as the fastest-growing therapeutic area OCALA, Fla., Sept. 25, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the Japan Patent Office has issued a patent covering the Company’s proprietary use of Ampligen® (Rintatolimod) in combination with checkpoint inhibitors (anti-PD-1 or anti-PD-L1 antibodies) for the treatment of cancer. “We remain committed to strengthening our global intellectual property protection for Ampligen as we continue to advance its clinical development. This Japan patent – which does not expire until December 20, 2039 –...

Continue reading

Allied Energy Corporation Signs MOU to Develop Option Agreement on Silver Reef Gold Property in California

DALLAS, Sept. 25, 2025 (GLOBE NEWSWIRE) — Allied Energy Corporation (OTC: AGYP) (the “Company”), a diversified energy and resource development company, today announced it has entered into a Memorandum of Understanding (MOU) with Puma Gold LLC regarding the potential acquisition of an interest in the Silver Reef Gold Property, located in San Bernardino County, California. The MOU outlines the framework for a proposed Option Agreement, which the parties intend to finalize within the coming weeks. If completed, the definitive Option Agreement would grant Allied the right to earn a controlling interest in the Silver Reef Property through a three-phase earn-in program, including staged cash payments, share issuances, and multi-million-dollar work commitments. “While this is not yet a definitive option agreement, the signing of this...

Continue reading

CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity

Company to deliver oral and poster presentations for data on leronlimab’s action on PD-L1 expression and patient survival in triple-negative breast cancer VANCOUVER, Washington, Sept. 25, 2025 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including triple-negative breast cancer (TNBC) and colorectal cancer (CRC), will present a poster and an oral presentation at the AACR Special Conference in Cancer Research: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity, taking place September 24, to September 27, 2025, in Montreal, Canada. Metastatic triple-negative breast cancer (mTNBC) is...

Continue reading

NioBay Appoints First Members of its Technical Advisory Committee

MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) — NioBay Metals Inc. (“NioBay” or the “Company“) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce the appointment of the first members of its Technical Advisory Committee. This committee will assist the Board of Directors and management in the next phases of the Company’s development. These first members represent fields as varied as academia, geology, metallurgy, and Indigenous relations, as well as knowledge of the niobium market. We believe that the addition of this committee will allow NioBay to increase its credibility with the market and potential partners. This is a first round of appointments, and other members could join this committee by the end of the year, always with the aim of developing the Company’s bench strength in areas of relevant expertise. Members...

Continue reading

Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion

Beta version of PredicTcell™ expands training dataset to ~1.4 million and total dataset to over 6.7 billion records. Potential future T cell therapies could reliably bind to their target nearly every time, dramatically raising the probability of success.WARREN, N.J., Sept. 25, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced significant progress in the development of its proprietary PredicTcell™ platform, designed to accelerate precision immunotherapy development and efficacy through advanced machine learning and transformer-based models. The platform is being developed with the support of Microsoft (Nasdaq: MSFT) and Databricks, leveraging their advanced cloud and data technologies to enable scalability and efficiency. The alpha version of PredicTcell...

Continue reading

Perma-Fix Founder Dr. Louis Centofanti Honored with Industry Innovation Award at EI Digest Gathering 2025

ATLANTA, Sept. 25, 2025 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company” or “Perma-Fix”) today announced that its founder and Executive Vice President of Strategic Initiatives, Dr. Louis Centofanti, has been awarded the Industry Innovation Award at the recent 2025 EI Digest Gathering in San Diego, California. The EI Digest Gathering is a premier executive-level conference focused on the commercial management of hazardous and universal wastes across North America. Dr. Centofanti received a standing ovation as he was recognized for nearly five decades of pioneering advancements that have redefined nuclear and hazardous waste treatment. Earlier in his career, Dr. Centofanti co-founded PPM, Inc., where he developed a first-of-its-kind process to destroy polychlorinated biphenyls (PCBs) in oil...

Continue reading

Terra Innovatum and GSR III Acquisition Corp. Announce $37.5 Million Equity Financing in Connection with Business Combination

– PIPE led by Segra Capital Management – Proceeds from the financing and SPAC trust, net of redemptions and expenses, will be used to support licensing and construction of Terra Innovatum’s first-of-a-kind SOLO™ micro-modular reactor – Extraordinary general meeting of shareholders to approve proposed business combination is scheduled for October 7, 2025, at 11:00 a.m. ET – Post-combination company expected to trade on Nasdaq under the ticker symbol NKLR shortly after the closing NEW YORK and AUSTIN, Texas, Sept. 25, 2025 (GLOBE NEWSWIRE) — Terra Innovatum Srl (“Terra Innovatum,” or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. (Nasdaq: GSRT), today announced that they have secured $37.5 million in committed financing in connection with their previously...

Continue reading

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Increases total holdings to 1,712,195 HYPE LAGUNA HILLS, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) — Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced that it has acquired an additional 176,422 HYPE tokens, expanding its total holdings to 1,712,195 HYPE purchased at an average price of $38.25 per token. “The Hyperliquid ecosystem continues to demonstrate the central role that HYPE has in both on-chain governance and enabling the associated governance outcomes, as seen with the recent USDH stablecoin proposals,” said Hyunsu Jung, Interim Chief Executive Officer. “Following the upcoming mainnet upgrade, a minimum stake of 200,000 HYPE will be required to qualify as an eligible quote asset on HyperCore. We see this as an opportunity for Hyperion DeFi to directly participate in new ecosystem deployments.” This...

Continue reading

ZenaTech Signs Offer to Acquire Colorado Land Surveying Firm, Expanding National Drone as a Service (DaaS) Business into a $36 Billion US Surveying and Mapping Market

VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces that it has signed an offer to acquire a long-established Colorado-based land surveying firm with a portfolio developers, municipalities, and utilities customers. When closed, this will mark ZenaTech’s first DaaS location in its Central West US region, expanding the company’s rapidly growing national presence. The firm to be acquired has a well-respected reputation of providing surveying services, including monumented land surveys, comprehensive property surveys, topographic surveys, and drone aerial topographic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.